Geneesmiddelenbeleid

This procedure concerns the Dutch government's input and written consultations regarding European Union medicines policy. It focuses on how the Netherlands contributes to the development and regulation of pharmaceuticals at the EU level to ensure healthcare quality and accessibility. This affects pharmaceutical companies, healthcare providers, and patients. It may influence how medicines are approved, priced, and distributed across the EU.